Therapeutic Efficacy of Orally Delivered Doxorubicin Nanoparticles in Rat Tongue Cancer Induced by 4-Nitroquinoline 1-Oxide
Clicks: 474
ID: 54447
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
82.5
/100
474 views
345 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #3 of 10 articles by views in advanced pharmaceutical bulletin
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Purpose: Oral cancer is one of the most significant cancers in the world, and squamous cell
carcinoma makes up about 94% of oral malignancies. The aim of the present study was to
compare the efficacy of doxorubicin plus methotrexate - loaded nanoparticles on tongue
squamous cell carcinoma induced by 4NQO and compare it with the commercial
doxorubicin and methotrexate delivered orally on seventy SD male rats.
Methods: 70 rats were divided into five groups. During the study, the animals were weighed
by a digital scale once a week. Number of mortalities was recorded in the data collection
forms. At the end of the treatment, biopsy samples were taken from rat tongues in order to
evaluate the severity of dysplasia and the extent of cell proliferation. The results were
analyzed using ANOVA, descriptive statistics and chi-square test.
Results: No statistically significant difference was found in the mean weight of five groups
(p>0.05). No significant relationship was found between groups and mortality rate (P = 0.
39). In addition, there was a significant relationship between groups and the degree of
dysplasia (P <0.001). The statistical analysis showed a significant relationship between
groups and the rate of cell proliferation (p <0.001).
Conclusion: The results of the present study showed that the use of doxorubicin plus
methotrexate - loaded nanoparticles orally had more therapeutic effects than commercial
doxorubicin plus methotrexate.
| Reference Key |
khiavi2015therapeuticadvanced
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Khiavi, Monir Moradzadeh;Rostami, Ahamd;Hamishekar, Hamed;Abassi, Mehran Mesgari;Aghbali, Amirala;Salehi, Roya;Abdollahi, Bita;Fotoohi, Soheila;Sina, Mahmud; |
| Journal | advanced pharmaceutical bulletin |
| Year | 2015 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.